###begin article-title 0
###xml 65 70 <span type="species:ncbi:9606">Human</span>
Genetic Regulation of alpha-Synuclein mRNA Expression in Various Human Brain Tissues
###end article-title 0
###begin p 1
Conceived and designed the experiments: OCF. Performed the experiments: CL LS. Analyzed the data: CL LS OCF. Contributed reagents/materials/analysis tools: DG KDC JRB JNB CH KAWB. Wrote the paper: OCF.
###end p 1
###begin p 2
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 480 487 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 768 772 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 883 887 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1130 1134 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1181 1185 1169 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1343 1347 1331 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1404 1409 1392 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA-</italic>
###xml 1444 1448 1432 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1560 1564 1548 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1642 1646 1630 1634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1734 1738 1722 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 495 500 <span type="species:ncbi:9606">human</span>
Genetic variability across the SNCA locus has been repeatedly associated with susceptibility to sporadic Parkinson's disease (PD). Accumulated evidence emphasizes the importance of SNCA dosage and expression levels in PD pathogenesis. However whether genetic variability in the SNCA gene modulates the risk to develop sporadic PD via regulation of SNCA expression remained elusive. We studied the effect of PD risk-associated variants at SNCA 5' and 3'regions on SNCA-mRNA levels in vivo in 228 human brain samples from three structures differentially vulnerable to PD pathology (substantia-nigra, temporal- and frontal-cortex) obtained from 144 neurologically normal cadavers. The extensively characterized PD-associated promoter polymorphism, Rep1, had an effect on SNCA-mRNA levels. Homozygous genotype of the 'protective', Rep1-259 bp allele, was associated with lower levels of SNCA-mRNA relative to individuals that carried at least one copy of the PD-risk associated alleles, amounting to an average decrease of approximately40% and >50% in temporal-cortex and substantia-nigra, respectively. Furthermore, SNPs tagging the SNCA 3'-untranslated-region also showed effects on SNCA-mRNA levels in both the temporal-cortex and the substantia-nigra, although, in contrast to Rep1, the 'decreased-risk' alleles were correlated with increased SNCA-mRNA levels. Similar to Rep1 findings, no difference in SNCA-mRNA level was seen with different SNCA 3'SNP alleles in the frontal-cortex, indicating there is brain-region specificity of the genetic regulation of SNCA expression. We provide evidence for functional consequences of PD-associated SNCA gene variants in disease relevant brain tissues, suggesting that genetic regulation of SNCA expression plays an important role in the development of the disease.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Spillantini1">[1]</xref>
###xml 296 299 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Polymeropoulos1">[2]</xref>
###xml 300 303 300 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Zarranz1">[4]</xref>
###xml 331 334 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Singleton1">[5]</xref>
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Ibanez1">[9]</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 752 756 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Farrer1">[10]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Miller1">[11]</xref>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1130 1133 1130 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Fuchs1">[6]</xref>
###xml 1134 1137 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Ibanez1">[9]</xref>
###xml 1244 1248 1244 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek1">[12]</xref>
###xml 1371 1382 1371 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post mortem</italic>
###xml 1410 1414 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Grundemann1">[13]</xref>
###xml 1463 1467 1463 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 88 91 <span type="species:ncbi:9606">Man</span>
Alpha-synuclein (SNCA) (Ensembl: ENSG00000145335; OMIM, Online Mendelian Inheritance in Man: MIM 163890) was the first gene found to be involved in Parkinson's disease (PD[MIM 168600]). SNCA aggregates have been identified within Lewy bodies, the pathological hallmark of PD [1]. Also, mutations [2]-[4] and copy number variations [5]-[9] in the SNCA gene have been identified in a few families with an early onset, autosomal dominant form of PD. Furthermore, accumulated evidence suggests that elevated levels of wild type SNCA lead to neuronal dysfunction and are sufficient to cause early onset familial PD. Genomic triplication of the region containing SNCA was shown to result in four fully functional copies of SNCA and 2-fold over-expression of SNCA mRNA and protein and a highly penetrant early-onset PD phenotype with cognitive impairment and autonomic dysfunction [10], [11]. Similarly, duplications of the wild-type SNCA gene result in a 1.5-fold elevation of SNCA expression and a slightly later onset of heritable PD that is characterized by a lower penetrance rate and a 'milder' phenotype than for the triplication [6]-[9], demonstrating the dose-dependent effect of SNCA on disease presentation. Furthermore, elevated levels of SNCA-mRNA have been reported in midbrain tissues [12] and in individual substantia nigra dopaminergic neurons from sporadic PD post mortem brains compared to controls[13]. These observations emphasize the importance of SNCA dosage and expression levels in PD pathogenesis.
###end p 4
###begin p 5
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Pals1">[14]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Myhre1">[18]</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Mueller1">[15]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Myhre1">[18]</xref>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 894 898 882 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 924 928 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Xia1">[19]</xref>
###xml 930 934 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Touchman1">[20]</xref>
###xml 1007 1011 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek2">[21]</xref>
###xml 1013 1017 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek3">[22]</xref>
###xml 1047 1051 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Cronin1">[23]</xref>
###xml 1074 1078 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1122 1123 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1376 1380 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek2">[21]</xref>
###xml 1382 1386 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek3">[22]</xref>
###xml 1035 1040 <span type="species:ncbi:10090">mouse</span>
###xml 1260 1265 <span type="species:ncbi:9606">human</span>
Several association studies have demonstrated that genetic variability across the SNCA locus is associated with susceptibility to sporadic PD [14]-[18]. Based on HapMap data SNCA has two major linkage disequilibrium (LD) blocks, a 5' block that extends to the promoter-enhancer region and a 3' block that comprises the 3'untranslated-region (UTR) and the 3' region of the gene [15], [18]. These studies confirmed the association of variants within both SNCA 5' and 3' LD-blocks with PD-risk, suggesting that the genetic regulation of SNCA expression might be mediated through different molecular mechanisms (transcriptional and post transcriptional) and could have an important role in the development of the disease. Previously, we extensively characterized the best confirmed associated genetic variation, Rep1, a polymorphic nucleotide repeat site located approximately10 kb upstream of the SNCA transcription start site [19], [20]. Using a reporter assay in a transiently transfected neuronal cell line [21], [22] and a transgenic mouse model [23], we demonstrated that SNCA-Rep1 had a reproducible effect on regulating transcriptional activity. In both model systems, the extended risk allele showed increased expression of the reporter construct and the human transgene, respectively; while the shorter PD-'protective' allele was associated with lower expression levels [21], [22].
###end p 5
###begin p 6
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 427 438 427 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post mortem</italic>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 236 241 <span type="species:ncbi:9606">human</span>
Here we aim to reveal the functional consequence of genetic variations in the SNCA genomic region. We studied the effect of the Rep1 variant as well as other PD risk-associated variants on SNCA-mRNA steady state levels in vivo in three human brain structures differentially vulnerable to PD; i.e. frontal cortex, temporal cortex and mid-brain including the substantia nigra (SN). Our comprehensive analysis was performed using post mortem matched brain tissues from unaffected individuals to directly assess the genetic contribution to the regulation of SNCA expression, avoiding other confounding factors arising from the neurodegeneration associated with PD.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Effect of secondary (non-genetic) variables on SNCA-mRNA level
###end title 8
###begin p 9
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA/SYP</italic>
###xml 127 134 127 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t001">Table 1</xref>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
SNCA-mRNA fold levels (SNCA/SYP) were measured in 228 brain tissue samples obtained from 144 subjects (83% white, 56.5% males; Table 1). First, we assessed the correlation of SNCA-mRNA expression with confounding factors that might affect RNA levels. All midbrain including substantia nigra (SN) samples were obtained from white individuals. SNCA mRNA folds levels in midbrain including SN (n = 34) were not correlated with sex (P = 0.187), age (P = 0.735), or PMI (p = 0.177). Similarly, no correlations of SNCA-mRNA levels were observed in temporal (n = 77) and frontal cortex (n = 117) with sex (P = 0.49, 0.46), race (P = 0.59, 0.14), age (P = 0.35, 0.742), or PMI (P = 0.85, 0.7).
###end p 9
###begin title 10
Demographic description of the brain samples.
###end title 10
###begin p 11
FC- frontal cortex, TC-temporal cortex, SN-substantia nigra. PMI- post mortem interval.
###end p 11
###begin p 12
###xml 375 377 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1092 1100 1092 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g001">Figure 1</xref>
###xml 1151 1155 1151 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 146 156 <span type="species:ncbi:328819|species:ncbi:379362|species:ncbi:219650|species:ncbi:329529|species:ncbi:133823|species:ncbi:261389|species:ncbi:184426|species:ncbi:261384|species:ncbi:302169">e. samples</span>
Next, the effect of specificity of the brain tissue region on SNCA expression was assessed. To carry out this analysis we used matched samples, i.e. samples of different brain structures obtained from the same cadaver. Frontal cortex showed significantly lower levels of SNCA-mRNA compared with midbrain including SN (n = 9; P = 0.001) and temporal cortex (n = 75; P = 1.6x10-9). The average SNCA-mRNA fold levels observed in the frontal cortex samples was approximately 50% less from the average SNCA-mRNA fold levels detected in the temporal cortex and in the midbrain including SN of the same individuals. Comparison of SNCA mRNA fold levels between matched samples of temporal cortex and midbrain including SN revealed no differences (n = 7, P = 0.37). Furthermore, we were able to carry out a direct comparison of all three brain regions in 7 cadavers from whom all brain regions were available, showing that the average fold expression levels of SNCA-mRNA are similar in midbrain including SN and temporal cortex and nearly twice the average fold levels observed in the frontal cortex (Figure 1). Thus, temporal cortex may serve as a mirror for SNCA-mRNA expression levels in the substantia nigra.
###end p 12
###begin title 13
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
Average fold expression of SNCA-mRNA in three matched brain regions obtained from the same subjects (n = 7).
###end title 13
###begin p 14
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 131 145 131 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP- and ENO2-</italic>
###xml 181 189 181 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 236 240 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
Fold levels of SNCA-mRNA were assayed by real-time RT-PCR using TaqMan technology and calculated relative to the geometric mean of SYP- and ENO2- mRNAs reference control using the 2-DeltaCt method. The bar graph presents the average of SNCA-mRNA fold expression (mean+/-S.E.M) of the 7 subjects for each brain region. SN-substantia nigra; TC-temporal cortex; FC- frontal cortex.
###end p 14
###begin title 15
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
Effect of variants in the 5' region of SNCA on SNCA-mRNA levels in different brain tissues
###end title 15
###begin p 16
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 196 204 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g002">Figure 2</xref>
We studied the effect of variants in the promoter enhancer region of SNCA on SNCA mRNA levels. Three polymorphisms were tested: two SNCA 5' region tagging SNPs (rs2619363 and rs2583988) and Rep1 (Figure 2).
###end p 16
###begin title 17
###xml 34 39 <span type="species:ncbi:9606">human</span>
A schematic representation of the human SNCA gene with the relative positions of the markers.
###end title 17
###begin p 18
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
Organization of the human SNCA locus: translated exons, wide black solid boxes; 5' and 3'UTR, narrow black solid boxes; introns and intergenic regions, grey line. The relative positions of the genetic variants are indicated above, asterisks designate variants that were associated with SNCA-mRNA.
###end p 18
###begin p 19
###xml 70 77 70 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t002">Table 2</xref>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
All samples were genotyped for both the rs2619363 and rs2583988 SNPs; Table 2 summarizes the allele frequencies in our samples. The tagging SNPs rs2619363 and rs2583988 in the promoter of the SNCA gene did not show any correlation to SNCA mRNA in the midbrain including SN (P = 0.58, 0.92) the temporal cortex, (P = 0.68, 0.95) or the frontal cortex (P = 0.68, 0.84).
###end p 19
###begin title 20
Rep1 allele frequencies of the study group.
###end title 20
###begin p 21
No.- total number of alleles (2 per individual); % allele frequency.
###end p 21
###begin p 22
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t003">Table 3</xref>
###xml 380 389 380 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g003">Figure 3A</xref>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 700 709 700 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g003">Figure 3A</xref>
###xml 849 853 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1095 1099 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1203 1212 1203 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g003">Figure 3B</xref>
###xml 1398 1402 1398 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1531 1535 1531 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek1">[12]</xref>
###xml 1759 1768 1759 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g003">Figure 3C</xref>
###xml 1809 1816 1809 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t004">Table 4</xref>
###xml 843 848 <span type="species:ncbi:9606">human</span>
We then tested for correlation with Rep1 genotypes. A summary of Rep1 allele frequencies of the studied samples is presented in Table 3. Analysis of the temporal cortex (n = 77) indicated that individuals homozygous for the PD-'protective' genotype 259/259 (n = 8) had lower SNCA-mRNA levels than individuals carrying the 259/261, 261/261, 259/263, 261/263 and 263/263 genotypes (Figure 3A; P = 0.02). In the temporal cortex Rep1 259/259 demonstrated an average 0.59 fold SNCA-mRNA expression level compared with an average 1.00, 0.94, 0.95, 0.83 and 0.90 fold expression level of SNCA-mRNA in the five other genotypes 259/261, 261/261, 259/263, 261/263 and 263/263 genotypes carriers, respectively (Figure 3A). From these results we calculated that individuals who carried two copies of the PD 'protective' Rep1-259 bp, had reduced levels of human SNCA-mRNA, amounting to a nearly 40% decrease relative to individuals that carried at least one copy of the PD-risk associated alleles. Similarly, in the midbrain including SN samples (n = 34) a 50-65% decrease in the average expression level of SNCA-mRNA was observed with the 259/259 genotype (n = 3) when compared to each of the other Rep1 genotypes (Figure 3B). This reduction effect of the 259/259 genotype did not show, however, a trend towards significance which might be explained by the small size of the group and the large variability in SNCA-mRNA levels within each genotype group (resulting from the neuronal cell heterogeneity of the mid brain/substantia nigra tissue)[12]. In contrast, no significant correlation of the Rep1 site with SNCA-mRNA levels was identified in the frontal cortex (n = 117; P = 0.91), suggesting that Rep1 might affect SNCA expression in a brain-region specific manner (Figure 3C). A summary of the results is listed in Table 4.
###end p 22
###begin title 23
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Effect of the SNCA-Rep1 promoter genotypes on human SNCA-mRNA expression levels in human brains.
###end title 23
###begin p 24
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 323 331 323 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 442 446 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 575 580 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 585 589 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO2</italic>
###xml 607 615 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007480.s002">Table S2</xref>
###xml 686 690 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 747 751 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1118 1120 1114 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1127 1129 1123 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
Individuals were genotyped for Rep1. Three brain regions were analyzed: temporal cortex (A), midbrain including SN (B) and frontal cortex (C). In each brain region fold levels of human SNCA-mRNA were assayed by real-time RT-PCR using TaqMan technology and calculated relative to human SYP-mRNA reference control using the 2-DeltaCt method. (A) Analysis of the temporal cortex showed that the protective genotype 259/259 correlates with lower SNCA-mRNA levels then the five other genotypes (P = 0.02). The association trend was confirmed in a subset of samples using also the GAPDH and ENO2 reference genes (Table S2). (B) In the midbrain including SN the 259/259 correlates, with lower SNCA-mRNA levels. (C) No correlations of Rep1 genotypes with SNCA-mRNA levels were detected in the frontal cortex. For each genotype the box plot represents the analysis performed using all brain samples available from the specific brain region, each of which was analyzed twice independently, each time in duplicate. The average values are presented in 'X'. The box plot shows the median (horizontal line inside the box) and the 25th and 75th percentiles (horizontal borders of the box). The range between the 25th and 75th percentiles is the interquartile-range (IQR). The whiskers show the minimal and maximal values inside the main data body.
###end p 24
###begin title 25
SNPs analyzed in the study with allele frequencies.
###end title 25
###begin p 26
No.- total number of alleles (2 per individual); MAF- the minor allele frequency.
###end p 26
###begin p 27
daggerHapMap data base. *MAF reported in PD-SNCA association studies.
###end p 27
###begin title 28
Summary of the genetic correlations between genetic variants at SNCA locus and SNCA-mRNA levels.
###end title 28
###begin p 29
' = ' no correlation, *no trend towards significance, FC- frontal cortex, TC-temporal cortex, SN-substantia nigra.
###end p 29
###begin title 30
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
Effect of SNPs in the 3' region of SNCA on SNCA-mRNA levels in different brain tissues
###end title 30
###begin p 31
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g001">Figure 1</xref>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t002">Table 2</xref>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 468 484 468 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g004">Figure 4 A and B</xref>
###xml 696 705 696 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g004">Figure 4A</xref>
###xml 819 823 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g004">Figure 4B</xref>
###xml 961 965 961 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1002 1011 1002 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g004">Figure 4C</xref>
###xml 1014 1018 1014 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1096 1105 1096 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g005">Figure 5A</xref>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g005">Figure 5B</xref>
###xml 1210 1214 1210 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1237 1244 1237 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t004">Table 4</xref>
###xml 1304 1313 1304 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007480-g005">Figure 5C</xref>
###xml 1367 1371 1367 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1517 1524 1517 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t004">Table 4</xref>
###xml 1715 1719 1715 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1795 1799 1795 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2058 2062 2058 2062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2168 2175 2168 2175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t004">Table 4</xref>
The effect of the SNCA 3' region on SNCA mRNA levels was tested with three SNPs: the rare rs17016074 and the two 3' region common tagging SNPs rs356219 and rs365165 (Figure 1). All samples contained the rs356219, rs365165, and rs17016074 SNP genotypes and the allele frequencies in our study group are summarized in Table 2. Genotypes of SNP rs356219 (G/A) showed an effect on SNCA mRNA levels in temporal cortex (P = 0.013) and midbrain including SN tissue (P<0.05) (Figure 4 A and B). In the temporal cortex the homozygous rs356219 'protective' AA genotype (n = 29) showed higher expression levels of SNCA mRNA than the GA and the GG genotypes (n = 38, 10), amounting to a nearly 40% increase (Figure 4A). In the substania nigra, the homozygous AA and the heterozygous GA genotypes (n = 12, 16) correlate with higher SNCA mRNA levels than the risk genotype GG (n = 6) (Figure 4B). In the frontal cortex, on the contrary, no correlation was identified between SNCA mRNA levels and rs356219 genotypes (Figure 4C). SNCA mRNA levels were also correlated with SNP rs365165 (G/A) in temporal cortex (Figure 5A, P<0.05) and midbrain including SN (Figure 5B, P<0.05), following the same correlations of genotypes to SNCA mRNA fold expression (Table 4); while no correlation was observed in the frontal cortex (Figure 5C), similar to the results obtained for the downstream SNCA 3' SNP. Thus, as expected based on the high LD between these SNPs, the results observed for SNP rs365165 supported the findings of SNP rs356219 (Table 4). Of note the magnitude of the SNPs effect on SNCA-mRNA fold expression was larger for SNP rs356219. Analysis of the rare (<5%) rs17016074 suggested a possible effect of the minor allele on SNCA mRNA reduction, since the homozygous AA (n = 1 of 77) had a lower level of SNCA mRNA in the temporal cortex and the heterozygous AG (n = 1 of 34) revealed a lower level in the midbrain including SN, which will need to be explored with a larger group (data not shown). The frontal cortex region did not show a significant correlation with SNCA mRNA folds levels with any of the genotypes at the 3' region SNPs. A summary of the results is listed in Table 4.
###end p 31
###begin title 32
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Effect of SNP rs356219, 3'region genotypes, on human SNCA-mRNA expression levels in human brains.
###end title 32
###begin p 33
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 331 339 331 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;Ct</sup>
###xml 446 450 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 579 584 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 589 593 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO2</italic>
###xml 611 619 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007480.s002">Table S2</xref>
###xml 814 818 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1185 1187 1181 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1194 1196 1190 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
Individuals were genotyped for SNP rs356219. Three brain regions were analyzed: temporal cortex (A), midbrain including SN (B) and frontal cortex (C). In each brain region fold levels of human SNCA-mRNA were assayed by real-time RT-PCR using TaqMan technology and calculated relative to human SYP-mRNA reference control using the 2-DeltaCt method. (A) Analysis of the temporal cortex showed that the protective genotype AA correlates with higher SNCA-mRNA levels than the GA and GG genotypes (P = 0.013). The association trend was confirmed in a subset of samples using also the GAPDH and ENO2 reference genes (Table S2). (B) In the midbrain including SN the AA and AG genotypes correlate with higher SNCA-mRNA levels compared with the GG risk genotype (P<0.05). (C) No correlations of SNP rs356219 genotypes with SNCA-mRNA levels were detected in the frontal cortex. For each genotype the box plot represents the analysis performed using all brain samples available from the specific brain region, each of which was analyzed twice independently, each time in duplicate. The average values are presented in 'X'. The box plot shows the median (horizontal line inside the box) and the 25th and 75th percentiles (horizontal borders of the box). The range between the 25th and 75th percentiles is the interquartile-range (IQR). The whiskers show the minimal and maximal values inside the main data body.
###end p 33
###begin title 34
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Effect of SNP rs365165, 3'region genotypes, on human SNCA-mRNA expression levels in human brains.
###end title 34
###begin p 35
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 331 344 331 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
###xml 451 455 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1072 1074 1064 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1081 1083 1073 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
Individuals were genotyped for SNP rs365165. Three brain regions were analyzed: temporal cortex (A), midbrain including SN (B) and frontal cortex (C). In each brain region fold levels of human SNCA-mRNA were assayed by real-time RT-PCR using TaqMan technology and calculated relative to human SYP-mRNA reference control using the 2-DeltaDeltaCt method. (A) Analysis of the temporal cortex showed that the protective genotype AA correlates with higher SNCA-mRNA levels than the GA and GG genotypes (P<0.05). (B) In the midbrain including SN, the AA and AG genotypes correlate with higher SNCA-mRNA levels compared with the GG risk genotype (P<0.05). (C) No correlations of SNP rs365165 genotypes with SNCA-mRNA levels were detected in the frontal cortex. For each genotype, the box plot represents the analysis performed using all brain samples available from the specific brain region, each of which was analyzed twice independently, each time in duplicate. The average values are presented in 'X'. The box plot shows the median (horizontal line inside the box) and the 25th and 75th percentiles (horizontal borders of the box). The range between the 25th and 75th percentiles is the interquartile-range (IQR). The whiskers show the minimal and maximal values inside the main data body.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Myers1">[24]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Emilsson1">[25]</xref>
###xml 674 678 674 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek1">[12]</xref>
###xml 1093 1097 1093 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1289 1293 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1707 1711 1707 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Pals1">[14]</xref>
###xml 1712 1716 1712 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Myhre1">[18]</xref>
###xml 293 298 <span type="species:ncbi:9606">human</span>
###xml 1137 1143 <span type="species:ncbi:9606">people</span>
Finding interesting correlations between genetic variants and gene expression levels does not necessarily require a comparison between tissues from both affected cases and controls. Significant differences in gene expression levels were also shown to be associated with different genotypes in human tissues of unaffected individuals [24], [25]. Identification of such genetic expression effects in a disease relevant tissue could provide important information for determining which variants to pursue in functional studies and which will further our understanding of the underlying biology of associations with the disease of interest. We previously reported differences in SNCA-mRNA expression levels between PD cases and controls[12]. However, in this current report, we analyzed unaffected brains, which allow us to overcome methodological and interpretative challenges that arise from the massive cell loss, particularly neuronal loss, along with other pathologic processes accompanying neurodegeneration that may influence expression. Following this approach, we looked for variations in SNCA expression in the brains of unaffected people (age matched to late-onset PD). Specifically, in the present study we focus on genetic regulation of RNA. Therefore, we looked for variations in SNCA mRNA levels and tested for association with PD-associated variants positioned within putative regulatory regions for RNA expression: 1) the 5' region of the gene which presumably influences transcription and 2) the 3' UTR and 3' of the gene that most likely affects post-transcriptional regulation. All variants chosen for the present study had been repeatedly reported to confer increased risk for developing PD [14]-[18]. The five analyzed SNPs are located within evolutionary highly conserved regions, and the two 5' SNPs were also in or very close to potential binding sites for transcription factors (data not shown).
###end p 37
###begin p 38
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Farrer2">[26]</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Maraganore1">[29]</xref>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 380 387 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek2">[21]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek3">[22]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek4">[30]</xref>
###xml 581 596 581 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">control subject</sub>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Fuchs2">[31]</xref>
###xml 648 663 648 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">control subject</sub>
###xml 743 750 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 969 973 969 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1074 1078 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Myhre1">[18]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Farrer2">[26]</xref>
###xml 1085 1089 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Maraganore1">[29]</xref>
###xml 1237 1241 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek3">[22]</xref>
###xml 1260 1264 1260 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Cronin1">[23]</xref>
###xml 1369 1373 1369 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1452 1456 1452 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 517 522 <span type="species:ncbi:9606">human</span>
###xml 754 759 <span type="species:ncbi:9606">human</span>
###xml 1248 1253 <span type="species:ncbi:10090">mouse</span>
In the 5' region we found that, among the polymorphic loci tested, only variation at the Rep1 locus was responsible for differences seen in SNCA-mRNA levels. Previously, we extensively characterized the functional significance of the PD-associated Rep1 polymorphic site [26]-[29] and its contribution to the transcriptional regulation of SNCA in an in vitro cell-based system and in vivo using a transgenic mouse model [21], [22], [30]. Recently, Fuchs and colleagues reported Rep1's effect on SNCA protein levels in human blood, but failed to detect an effect in brain samples (N control subject = 24) [31]. Here using a much large sample size (N control subject = 144) we demonstrate for the first time the regulatory effect of Rep1 alleles in vivo in human brain structures relevant to the disease providing further direct, functional evidence for the reported genetics associations; i.e. in PD-affected brain regions the 'protective' genotype correlated with lower SNCA-mRNA levels compared with all the other genotypes carrying one or two PD-risk alleles (261 and 263) [18], [26]-[29]. The direction of the Rep1 alleles' effect on SNCA-mRNA levels is consistent with our previous observations using both a cell-based reporter system[22] and a mouse model [23]. Furthermore, our finding lends support to the general hypothesis that an increase in the expression of SNCA may also contribute to the common, 'idiopathic' PD phenotype, while decreased SNCA levels protect from this devastating disease.
###end p 38
###begin p 39
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Fuchs2">[31]</xref>
###xml 1118 1122 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1318 1322 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1628 1632 1628 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Beyer1">[32]</xref>
###xml 1634 1638 1634 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Lee1">[33]</xref>
###xml 1736 1740 1736 1740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2097 2101 2097 2101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2122 2126 2122 2126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek1">[12]</xref>
###xml 2128 2132 2128 2132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Grundemann1">[13]</xref>
###xml 2134 2138 2134 2138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Kingsbury1">[34]</xref>
###xml 2139 2143 2139 2143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Dachsel1">[36]</xref>
###xml 2262 2266 2262 2266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2314 2318 2314 2318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
In the 3' region, we found evidence for a regulatory role for all tested SNPs. In contrast to the Rep1 effect, however, the 'protective' genotype at the 3' region defined by each of the common tagging SNPs is associated with higher SNCA-mRNA levels in disease affected brain tissues (midbrain including SN and temporal cortex). With both of the common 3' region tagging SNPs, rs356219 and rs365165, the 'protective' AA genotype correlated with higher SNCA-mRNA in the temporal cortex, while both the homozygous 'protective' and the heterozygous genotypes (AA and GA) correlated with higher mRNA levels in the midbrain including SN. In general, our findings are in agreement with a recent smaller scale study reporting that the protective rs356219 genotype (AA) is accompanied by higher mRNA levels in the cerebellum, whereas the heterozygous genotype (GA) correlated with the higher mRNA levels in the midbrain including SN. The subtle differences from this previous study might be from the result of the smaller sample size studied [31]. Although these findings run contrary to the conventional hypothesis that lower SNCA expression confers PD-protection, it might be that rs356219, rs365165, or any other SNP in the 3' LD block (extended to include intron 4), exerts a regulatory effect not simply by changing total SNCA-mRNA levels but by a different molecular mechanism, such as splicing, to change the relative levels of the different splice forms (e.g., NACP140/112). For example, it was suggested that exon 5 deletion (NACP112) result in enhanced aggregation due to a significant shortening of the unstructured C-terminus[32], [33]. Thus, one can speculate that although the protective genotype led to an increase in the overall SNCA-mRNA levels, the proportion of the aggregated isoform may decrease providing PD-protection. Additional assays directly measuring the association of the full and spliced forms with SNPs in the 3' region will be required to settle this question. Alternatively, acknowledging the contradictory findings in the field with respect to ups and down regulation of SNCA levels in PD brains [12], [13], [34]-[36] one cannot exclude the interpretation that the association between the 3' SNPs and sporadic PD is the result of lower SNCA expression levels. Nevertheless, alteration in SNCA-mRNA levels might contribute to disease pathogenesis in many but, perhaps, not all cases of sporadic PD.
###end p 39
###begin p 40
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
Our study examined several SNPs in various brain tissues for association with expression, and as such, is subject to false positive associations. Therefore, P values should be interpreted with caution. After Bonferroni adjustment for 18 hypotheses (6 variants x 3 tissues), the associations with all variants became non-significant. However, given that these were not independent hypotheses (brain tissues from the same individuals and with clear correlation of expression, SNPs in linkage disequilibrium), this may be an overly conservative interpretation. The results of this study suggest an association between specific variants in SNCA and expression that warrants further investigation in a larger cohort such as a multi site meta analysis platform.
###end p 40
###begin p 41
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Braak1">[37]</xref>
###xml 617 621 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 677 681 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 877 881 877 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1230 1234 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
Our analysis included functionally and anatomically distinct brain regions from unaffected age-matched brains. Frontal cortex, temporal cortex, and substantia nigra are known to have differential susceptibility to PD pathology, ranging from severely afflicted substantia nigra, followed by temporal cortex that is involved in a later stage, to the frontal cortex, which is a late-developing structure that might be spared PD features [37]. Interestingly the genetic control identified in this study was not global (across all brain regions) but brain-region specific, indicating regionally differential regulation of SNCA-mRNA expression. Our results show that, in relation to SNCA-mRNA overall expression levels and genetic regulation, the temporal cortex mirrors the substantia nigra. Thus, it is possible that these two brain regions share regulatory mechanisms controlling SNCA expression. In contrast, the frontal cortex showed lower SNCA-mRNA levels and did not reflect the genetic regulation observed for the temporal cortex and the midbrain including SN. Thus, concerning the limited availability of substantia nigra region, temporal cortex may serve as a surrogate brain region carry out further studies on expression of SNCA and other genes in PD.
###end p 41
###begin p 42
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Pals1">[14]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Winkler1">[17]</xref>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 782 786 782 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 654 662 <span type="species:ncbi:9606">patients</span>
A critical question concerning the molecular pathogenesis of PD is what role SNCA plays in sporadic PD. Several recent association studies have demonstrated that genetic variability across the SNCA locus is associated with susceptibility to sporadic PD in many populations [14]-[17]. In this study, we demonstrated the functional consequence of genetic variations in the SNCA genomic region and showed that the genetic association of some variants correlates with biological function, in particular regulation of SNCA expression levels. This suggests that regulation of SNCA gene expression levels might be important in the development of sporadic PD in patients who do not express a mutated protein or who do not have an increase in gene copy number. Given that multiplications of SNCA have been implicated in familial PD, we suggest that a subtle increase in SNCA expression over decades confers an elevated risk for late-onset, sporadic PD.
###end p 42
###begin p 43
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Lewis1">[38]</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Qiao1">[40]</xref>
The results of our study advanced our understanding of the contribution of genetic variants within the SNCA locus to sporadic PD. Better understanding the molecular mechanisms modulating SNCA gene expression, may lead to novel therapeutic approaches based on reductions in SNCA levels [38]-[40].
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
Brain Samples
###end title 45
###begin p 46
###xml 177 184 177 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t001">Table 1</xref>
###xml 591 598 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t001">Table 1</xref>
###xml 759 770 759 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post mortem</italic>
Brain tissue samples, including midbrain/pons/substantia nigra (n = 34), temporal cortex (n = 77), and frontal cortex (n = 117), from neurologically healthy controls (n = 144) (Table 1) were obtained through the Kathleen Price Bryan Brain Bank (KPBBB) at Duke University, the Brain and Tissue Bank for developmental Disorders at the University of Maryland, the Layton Aging & Alzheimer's Disease Center at Oregon Health and Science University, and the National NeuroAIDS Tissue Consortium (NNTC). All post mortem interval (PMI) were <24 hours. Demographics for these samples are included in Table 1. All brain samples were collected from clinically and neuropathologically healthy cadavers who had no evidence of PD, AD or other neurodegenerative disorder at post mortem examination.
###end p 46
###begin title 47
DNA Extraction and Genotyping
###end title 47
###begin p 48
###xml 485 493 485 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007480.s001">Table S1</xref>
###xml 946 950 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek3">[22]</xref>
###xml 952 956 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Farrer2">[26]</xref>
###xml 958 962 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Parsian1">[41]</xref>
###xml 1087 1113 1063 1089 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGGCATATTTGATTGCAA-3&#8242;</named-content>
###xml 1126 1152 1102 1128 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GACTGGCCCAAGATTAACCA-3&#8242;</named-content>
###xml 1161 1165 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Xia1">[19]</xref>
###xml 1570 1578 1546 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t002">Tables 2</xref>
###xml 1583 1584 1559 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007480-t003">3</xref>
Genomic DNA was extracted from brain tissues by the standard Qiagen protocol. Genotype determination of each Single Nucleotide Polymorphism (SNP) was performed by allelic discrimination using TaqMan SNP Genotyping Assays (Applied Biosystems, Foster City, CA). Each genomic DNA sample (20 ng) was amplified using TaqMan Universal PCR master mix reagent (Applied Biosystems, Foster City, CA) combined with the specific TaqMan SNP genotyping assay mix corresponding to the genotyped SNP (Table S1). The assays were carried out using the ABI 7900HT and the following conditions: 2 min at 50degreesC, 10 min at 95degreesC, 40 cycles: 15 sec at 95degreesC, and 1 min at 60degreesC. Genotype determination was performed automatically using the SDS version 2.2 Enterprise Edition Software Suite (Applied Biosystems, Foster City, CA). SNCA-Rep1 dinucleotide complex repeat polymorphism genotyping was carried out by size using previously published method [22], [26], [41]. Briefly: the SNCA-Rep1 region of each genomic DNA sample (20 ng) was PCR-amplified using fluorescently labeled forward FAM 5'-CCTGGCATATTTGATTGCAA-3' and reverse 5'-GACTGGCCCAAGATTAACCA-3' primers [19]. Genotypes were determined on an ABI 3730 using GeneMapper version 4.0 software (Applied Biosystems, Foster City, CA) for allelic size assessment. The Rep1 allele was determined according to the length of the PCR product (259 bp, 261 bp, 263 bp and 265 bp). All genotypes were tested for Hardy-Weinberg Equilibrium and allele frequencies compared to the public database and previously published results (Tables 2 and 3).
###end p 48
###begin title 49
RNA extraction and cDNA synthesis
###end title 49
###begin p 50
Total RNA was extracted from brain samples (100 mg) using TRIzol reagent (Invitrogen, Carlsbad, CA) followed by purification with an RNeasy kit (Qiagen, Valencia, CA) following the manufacturer's protocol. RNA concentration was determined spectrophotometrically at 260 nm, while the quality of the purification was determined by 260 nm/280 nm ratio that showed values between 1.9 and 2.1, indicating high RNA quality. Additionally, quality of sample and lack of significant degradation products was confirmed on an Agilent Bioanalyzer. The RNA Integrity Number (RIN) measurements were greater than 7 validating the RNA quality control. Next, cDNA was synthesized using MultiScribe RT enzyme (Applied Biosystems, Foster City, CA) under the following conditions: 10 min at 25degreesC and 120 min at 37degreesC.
###end p 50
###begin title 51
Real time PCR
###end title 51
###begin p 52
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek1">[12]</xref>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP),</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek1">[12]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-ChibaFalek4">[30]</xref>
###xml 715 719 689 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 814 817 788 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 1420 1433 1394 1399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 1449 1453 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1459 1462 1421 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 282 287 <span type="species:ncbi:9606">human</span>
Real-time PCR was used to quantify human SNCA mRNA levels as previously described [12]. Briefly, duplicates of each sample were assayed by relative quantitative real-time PCR using the ABI 7900 for analysis of the level of SNCA message as compared in brain tissues to mRNA encoding human synaptophysin (SYP), a presynaptic protein that has a similar expression pattern to SNCA[12], [30]. Each cDNA (10 ng) was amplified in duplicate in at least two independent runs (overall>/=4 repeats), using TaqMan Universal PCR master mix reagent (Applied Biosystems, Foster City, CA) and the following conditions: 2 min at 50degreesC, 10 min at 95degreesC, 40 cycles: 15 sec at 95degreesC, and 1 min at 60degreesC. The target SNCA cDNA was amplified using ABI MGB probe and primer set assay ID Hs00240906_m1, normalized to a SYP RNA control (ABI MGB probe and primer set assay ID Hs00300531_m1) (Applied Biosystems, Foster City, CA). As a negative control for the specificity of the amplification and to control for DNA contamination, we used RNA control samples that were not converted to cDNA (no-RT) and no-cDNA/RNA samples (no-template) in each plate. No observable amplification was detected. Data were analyzed with a threshold set in the linear range of amplification. The cycle number at which any particular sample crossed that threshold (Ct) was then used to determine fold difference. Fold difference was calculated as 2-DeltaDeltaCt; DeltaCt = [Ct(SNCA)-Ct (SYP)]. DeltaDeltaCt = [DeltaCt(sample)]-[ DeltaCt(calibrator)]. The calibrator was a particular brain RNA sample used repeatedly in each plate for normalization within and across runs. The variation of the DeltaCt values among the calibrator replicates was smaller than 10%.
###end p 52
###begin p 53
###xml 83 92 83 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enolase 2</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO2</italic>
###xml 133 136 133 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 329 338 329 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO2, SYP</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 490 498 490 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO2 SYP</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 725 734 725 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007480.s003">Figure S1</xref>
###xml 842 845 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ENO2</italic>
###xml 863 868 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 926 929 926 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 1036 1039 1036 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYP</italic>
###xml 376 381 <span type="species:ncbi:9606">human</span>
Of note is that three internal controls were compared: the neuronal specific genes Enolase 2 (ENO2 Hs00157360_m1) and synaptophysin (SYP Hs00300531_m1) and the house keeping gene glyceraldehydes-3-phosphate dehydrogenase (GAPDH Hs00999905_m1). For assay validation we generated standard curves for SNCA and each reference assay, ENO2, SYP and GAPDH using different amounts of human brain total RNA (0.1-100 ng). The slope of the relative efficiency plot for SNCA and each internal control (ENO2 SYP or GAPDH) was determined to validate the assays. The slope in the relative efficiency plots for SNCA and the reference genes were >0.1, showing a standard value required for the validation of the relative quantitative method (Figure S1). In addition, for a subset of brain samples (for each type of brain tissue) we used the geometric mean of SYP and ENO2 and the GAPDH as normalization controls and confirmed the selection of SYP as a representative normalization control for the entire brain set. Thus, for the extended study we chose SYP as the internal control.
###end p 53
###begin title 54
Statistical analysis
###end title 54
###begin p 55
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 322 326 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007480-Bengtsson1">[42]</xref>
###xml 846 847 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1002 1003 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1030 1031 1028 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
SNCA-mRNA fold expression value of each sample was analyzed repetitively and the results of all replicates were averaged. All average values were expressed as mean+/-S.E.M. Correlations were assessed by linear regression analyses. A log transformation (log2) was performed on all mRNA levels to assure normal distribution [42]. The general linear model (GLM) method was used to evaluate the effect of the primary explained variable (genotype) as well as other secondary variables (sex, age, PMI, ethnicity, tissue source) on the RNA levels. The GLM is a procedure unifying the ordinary linear regression and ANOVA as well as other procedures based on the least square computation such as ANCOVA. Since gender, age, PMI, ethnicity, and tissue source may also show an effect on the RNA levels, they were included in the model as factors. Where the P value of the maximal model remains significant, an effect of each single term was estimated calculating the type III sum of squares and the corresponding F value and its probability P. Correction for multiple testing employed the Bonferroni method. Tissues comparisons were done by paired t-tests. All analyses were carried out using STATA/IC10.0 statistical software (StataCorp, College Station, TX).
###end p 55
###begin p 56
The Bryan ADRC Autopsy and Brain Donation Program Database/Repository has been granted approval from the Duke University Health System Institutional Review Board for Clinical Investigations, eIRB# Pro 00016278. Subject's (or their Legally Authorized Representatives) participating in the Bryan ADRC Autopsy and Brain Donation Program Database/Repository have provided written consent for use of their data and brain specimens to be used for use in future research. The genetic and expression analysis of all brain tissues obtained for this study is covered by eIRB exemption #10141.
###end p 56
###begin title 57
Supporting Information
###end title 57
###begin p 58
TAQMAN Genotyping Assays *Primers and probe sequences available upon request.
###end p 58
###begin p 59
(0.03 MB DOC)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
Discovery and Confirmatory Samples Sets. FC- frontal cortex, TC-temporal cortex, SN-substantia nigra. PMI- post mortem interval. Total no.- indicates the entire samples set used in the initial discovery step (N = 228; reference gene, SYP); Replication- referrers to the subset of temporal cortex samples used in the validation step (n = 24; reference genes, SYP, ENO2 and GAPDH) to confirm key results.
###end p 61
###begin p 62
(0.03 MB DOC)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
###xml 141 146 <span type="species:ncbi:9606">human</span>
Relative efficiency plots of SNCA and the reference control genes. Validation curve of the Deltareal time assay for relative quantization of human SNCA-mRNA in brain relative to: (A) SYP-mRNA, (B) ENO2-mRNA, and (C) GAPDH-mRNA. Relative efficiency plots of SNCA and each of the normalization control genes were formed by plotting the log input amount (ng of total RNA) versus the DeltaCt = [Ct(SNCA)-Ct(SYP/ENO2/GAPDH)]. The slopes are all <0.1, which indicated the validation of the DeltaCt calculation in the range between 0.1-100 ng RNA with all three controls.
###end p 64
###begin p 65
(1.94 MB TIF)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
We thank the Kathleen Price Bryan Brain Bank (KPBBB) at Duke University funded by NIA AG028377, the National NeuroAIDS Tissue Consortium (NNTC), Layton Aging & Alzheimer's Disease Center at Oregon Health and Science University, and the Brain and tissue banks for developmental disorders, University of Maryland, Department of Pediatrics, for providing us with the brain tissues. We thank Dr. Jeanette McCarthy for contributory discussions and critical advice. We would like also to thank Dr. Randy Woltjer, Dr. Kathleen Hayden, Dr. Lauren Warren, Mari Szymanski, and John Ervin for their assistance in obtaining the required brain samples for the study.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Alpha-synuclein in Lewy bodies.
###end article-title 69
###begin article-title 70
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
###end article-title 70
###begin article-title 71
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
###end article-title 71
###begin article-title 72
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
###end article-title 72
###begin article-title 73
alpha-Synuclein locus triplication causes Parkinson's disease.
###end article-title 73
###begin article-title 74
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
###end article-title 74
###begin article-title 75
Genomic investigation of alpha-synuclein multiplication and parkinsonism.
###end article-title 75
###begin article-title 76
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.
###end article-title 76
###begin article-title 77
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.
###end article-title 77
###begin article-title 78
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.
###end article-title 78
###begin article-title 79
Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.
###end article-title 79
###begin article-title 80
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
###end article-title 80
###begin article-title 81
Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
###end article-title 81
###begin article-title 82
alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
###end article-title 82
###begin article-title 83
Multiple regions of alpha-synuclein are associated with Parkinson's disease.
###end article-title 83
###begin article-title 84
Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
###end article-title 84
###begin article-title 85
{alpha}-Synuclein and Parkinson disease susceptibility.
###end article-title 85
###begin article-title 86
Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
###end article-title 86
###begin article-title 87
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element.
###end article-title 88
###begin article-title 89
Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene.
###end article-title 89
###begin article-title 90
Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
###end article-title 90
###begin article-title 91
###xml 76 81 <span type="species:ncbi:9606">Human</span>
###xml 114 119 <span type="species:ncbi:10090">Mouse</span>
Expansion of the Parkinson Disease-Associated SNCA-Rep1 Allele Up-Regulates Human {alpha}-Synuclein in Transgenic Mouse Brain.
###end article-title 91
###begin article-title 92
###xml 20 25 <span type="species:ncbi:9606">human</span>
A survey of genetic human cortical gene expression.
###end article-title 92
###begin article-title 93
Genetics of gene expression and its effect on disease.
###end article-title 93
###begin article-title 94
alpha-Synuclein gene haplotypes are associated with Parkinson's disease.
###end article-title 94
###begin article-title 95
Meta-analysis of alpha synuclein/NACP polymorphism in Parkinson's disease in Japan.
###end article-title 95
###begin article-title 96
Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
###end article-title 96
###begin article-title 97
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
###end article-title 97
###begin article-title 98
Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
###end article-title 98
###begin article-title 99
Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
###end article-title 99
###begin article-title 100
Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers.
###end article-title 100
###begin article-title 101
Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form.
###end article-title 101
###begin article-title 102
Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
###end article-title 102
###begin article-title 103
Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.
###end article-title 103
###begin article-title 104
The ups and downs of alpha-synuclein mRNA expression.
###end article-title 104
###begin article-title 105
Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
###end article-title 105
###begin article-title 106
In vivo silencing of alpha-synuclein using naked siRNA.
###end article-title 106
###begin article-title 107
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.
###end article-title 107
###begin article-title 108
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
###end article-title 108
###begin article-title 109
Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease.
###end article-title 109
###begin article-title 110
Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels.
###end article-title 110
###begin p 111
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 111
###begin p 112
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by the Ellison Medical Foundation New Scholar award AG-NS-0441-08 (O.C) and the Institute for Genome Sciences and Policy at Duke University (O.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 112

